Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers develop saliva tapeworm test
"Horse owners will be able to purchase saliva collection kits through distributors and collect the saliva sample themselves".
Test enables horse owners to collect samples themselves

Researchers at Austin Davis Biologics have developed a saliva test to diagnose tapeworm burden in horses.

Writing in the journal Veterinary Clinical Pathology, researchers say the test could be more cost-effective and allow for targeted deworming strategies.

Speaking to The Horse, study author Corrine Austin said: “A limited number of drugs are available for treating equine helminths (worms) and, with no new chemical classes (drugs) in development, care must be taken to preserve the efficacy of the currently effective anthelmintics.

“The use of accurate diagnostic tests to detect tapeworm burdens and, hence, inform treatment, will reduce the use of anti-tapeworm anthelmintics. And that could therefore reduce the risk for resistance emergence.”

In the study, researchers collected serum and saliva samples from over 240 horses at a UK abattoir. The horses were examined for tapeworms and any present were counted.

The researchers then analysed the samples using an existing blood test - serologic ELISA - and the new saliva tapeworm test.

They found that the saliva test was just as accurate in detecting tapeworm burdens as the serologic ELISA test.

“Our test was capable of identifying horses with one or more tapeworms present, with a sensitivity (correctly identified horses with tapeworm burdens) of 83 per cent and specificity (correctly identified horses without tapeworm burdens) of 85%," explained Austin.

“The remaining few (positive horses) diagnosed as negative had burdens of less than 20 tapeworms, which is not considered to be a pathogenic (disease-causing) burden by experts; this is similar to worm egg counts for strongyles, where less than 200 eggs per gram is considered acceptable.

“It means that this test can be relied upon to correctly identify the majority of horses with a moderate/high burden and correctly identify all horses with pathogenic burdens.”

The saliva test is already available to horse owners in the UK and parts of Europe, and researchers hope it could soon make an appearance in the United States.

“Horse owners will be able to purchase saliva collection kits through distributors and collect the saliva sample themselves, before sending the sample back to the distributors, who will arrange for samples to be shipped to the U.K. for testing in our high-throughput lab,” said Austin.
 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.